Vol. 4, Issue 6 (2015)
A study to assess changes in the hematological profile in chronic kidney disease
Sneha V George, JoJo K Pullockara, Kumar Sai Sailesh, Mukkadan J K
Chronic kidney disease is a condition that affects kidney functions and if untreated, causes kidney failure. The aim of the study was to assess the hematological changes in chronic kidney disease of the patients. 50 chronic kidney disease patients were recruited for the present study by using convenience sampling technique. Data was collected from the medical records. It was observed that the main cause for Chronic kidney disease is type 2 diabetes mellitus in 90% cases, systemic hypertension in 86% cases, coronary artery disease in 72% cases, renal calculi in 30% cases and acute pyelonephritis in 4% cases. Our study agrees with the previous studies as we have observed significant decrease in the PCV and hemoglobin levels and increase in TLC, platelet count in patients with chronic kidney disease. We have observed that normocytic normochromic anemia is most common anemia in CKD patients. Further it was observed that type 2 diabetes mellitus and systemic hypertension are more common causes for CKD. From the present study, it may be concluded that anemia is the most common hematological changes in CKD patients. However, we recommend further detailed study in this regard to confirming the results.
How to cite this article:
Sneha V George, JoJo K Pullockara, Kumar Sai Sailesh, Mukkadan J K. A study to assess changes in the hematological profile in chronic kidney disease. The Pharma Innovation Journal. 2015; 4(6): 01-03.